| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227845A2 Mixture containing rare earths and use thereof |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227830A1 Method of inducing angiogenesis |
| 08/07/2002 | EP1227814A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227811A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |
| 08/07/2002 | EP1227804A2 Use of an aldosterone antagonist for treating restenosis |
| 08/07/2002 | EP1227791A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 08/07/2002 | EP1227734A2 Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 08/07/2002 | EP0986537B1 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362882A Use of catechin for preventing or treaitng coronary restenosts |
| 08/07/2002 | CN1362860A Low-molecular weight polymannuronate |
| 08/07/2002 | CN1362261A Health tonic containing rich lucid ganoderma selenium |
| 08/07/2002 | CN1362260A Medicine for treating anal disease and its prepn. |
| 08/07/2002 | CN1362255A Coronary heart disease treating Chinese medicine and its preparation |
| 08/07/2002 | CN1362249A Jinguzi capsule for clearing away heat and toxic material |
| 08/07/2002 | CN1362241A Nano gastrodia and sharpleaf gambirplant medicine and its preparation |
| 08/07/2002 | CN1362231A Nano Haizhu Chuanxiding medicine and its preparation |
| 08/07/2002 | CN1362230A Nano Lemai medicine and its preparation |
| 08/07/2002 | CN1362228A Nano heart fire-clearing away bezoar medicine and its preparation |
| 08/07/2002 | CN1362223A Nano Xinmaitong medicine and its preparation |
| 08/07/2002 | CN1362220A Nano Anemarrhenae, phellodendri and Rehmanniae medicine and its preparation |
| 08/07/2002 | CN1362217A Nano Bupleuri medicine for dispersing stagnated liver energy and its preparation |
| 08/07/2002 | CN1362214A Nano shortcape fleaband medicine and its preparation |
| 08/07/2002 | CN1362210A Nano Puerariae, Scutellariae and Coptidis medicine and its preparation |
| 08/07/2002 | CN1362209A Nano bezoar medicine for treating upper respiratory tract infection and its preparation |
| 08/07/2002 | CN1362200A Nano apoplexy-treating Zhongfenghuichun medicine and its preparation |
| 08/07/2002 | CN1362198A Nano Chinese angelica medicine and its preparation |
| 08/07/2002 | CN1362197A Nano Diaoxinxuekang medicine and its preparation |
| 08/07/2002 | CN1362196A Nano Guanxinsuhe medicine and its preparation |
| 08/07/2002 | CN1362193A Namo xinkeshu medicine and its preparation |
| 08/07/2002 | CN1362192A Nano xinnaoshutong medicine and its preparation |
| 08/07/2002 | CN1362191A Nano Folium Ginkgo medicine and its preparation |
| 08/07/2002 | CN1362190A Nano Yufengningxin medicine and its preparation |
| 08/07/2002 | CN1362187A Nano red sage medicine and its preparation |
| 08/07/2002 | CN1362186A Nano manyprickle acanthopanax root medicine and its preparation |
| 08/07/2002 | CN1362177A Nano xiaozhiling medicine for treaitng piles and its preparation |
| 08/07/2002 | CN1362175A Nano Naoliqing medicine and its preparation |
| 08/07/2002 | CN1362171A Nano notoginseng medicine and its preparation |
| 08/07/2002 | CN1362169A Nano piles treating medicine and its preparation |
| 08/07/2002 | CN1362164A Nano Huatuozaizao medicine and its preparation |
| 08/07/2002 | CN1362160A Nano Heavn king tonic medicine for mental discomfort and its preparation |
| 08/07/2002 | CN1362159A Nano shuxin syrup and preparation |
| 08/07/2002 | CN1362158A Nano Xinkaokang Medicine and its preparation |
| 08/07/2002 | CN1362152A Nano hypertension-treating bezoar medicine and its preparation |
| 08/07/2002 | CN1362151A Nano Mayinglong pile-treating musk medicine and its preparation |
| 08/07/2002 | CN1362147A Nano mixed red sage medicine and its preparation |
| 08/07/2002 | CN1362146A Nano Qingkailing medicine and its preparation |
| 08/07/2002 | CN1362125A Nano pulse beating restoring medicine and its preparation |
| 08/07/2002 | CN1362113A Nano coptidis-goat liver meidcine and its preparation |
| 08/07/2002 | CN1362103A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1362100A Nano Jiuhua medicine and its preparation |
| 08/07/2002 | CN1362093A Nano suxiaojiuxin medicine and its preparation |
| 08/07/2002 | CN1362089A Nano sanhuang medicine and its preparation |
| 08/07/2002 | CN1362087A Nano shengmai medicine and its preparation |
| 08/07/2002 | CN1362084A Nano coronary heart disease treating red sage medicine and its preparation |
| 08/07/2002 | CN1362077A Nano thrombus treating xinmaining medicine and its preparation |
| 08/07/2002 | CN1362076A Nano thrombus dredging medicine and its preparation |
| 08/07/2002 | CN1362075A Nano blood stasis dispersing medicine and its preparation |
| 08/07/2002 | CN1362074A Nano heart proteoting medicine and its preparation |
| 08/07/2002 | CN1362072A Nano heart nourishing medicine and its preparation |
| 08/07/2002 | CN1088708C Amidine derivatives useful as anti-platelet aggreaction inhibitors and vasodilators and their use |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/07/2002 | CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases |
| 08/07/2002 | CN1088563C Apocynum venetum health care tea |
| 08/06/2002 | US6429315 Process for preparing N6-substituted adenosine derivatives |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429232 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/06/2002 | US6429226 Prostaglandin derivatives with phenyl ring in omega chain; topical application |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429222 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/06/2002 | US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429202 Administering complex with phospholipids to prevent atherosclerosis and myocardial or cerebral infarctions; reduces formation of arterial plaques |
| 08/06/2002 | US6429197 Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 08/06/2002 | US6428812 Process for producing granules containing angiotensin-converting enzyme inhibiting peptides |
| 08/06/2002 | CA2208682C Fibrinogen receptor antagonists having substituted .beta.-amino acid residues and pharmaceutical compositions comprising the same |
| 08/06/2002 | CA2076060C Compounds named the adenophostins, their preparation and their therapeutic use |
| 08/06/2002 | CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059155A2 Modulation of calcium channel activity |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059126A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | WO2002059113A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |